Pretty smart question considering that I expect earnings for Curis to be reported early monday morning, and from a forward-looking perspective, how the market will react will likely depend on whether drug sales of its new medicine are up.
I was reading Roche's report this AM and didn't find mention of Erivedge on it. I don't believe they supply a breakdown of sales from all of their different drugs, but I'll scour the site some more all the same.
Yes the numbers are there for the year. Based on that I'm thinking in the $550k area for royalties for the quarter. Also don't assume earnings on Monday as the company has not announced. Don't assume based on Yahoo's notes.